Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-016856
Filing Date
2019-08-14
Accepted
2019-08-14 17:10:50
Documents
56
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20190630_10q.htm 10-Q 765592
2 EXHIBIT 31.1 ex_154774.htm EX-31.1 8908
3 EXHIBIT 31.2 ex_154775.htm EX-31.2 8918
4 EXHIBIT 32.1 ex_154776.htm EX-32.1 5850
  Complete submission text file 0001437749-19-016856.txt   3913809

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wint-20190630.xml EX-101.INS 703397
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20190630.xsd EX-101.SCH 43026
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20190630_cal.xml EX-101.CAL 36083
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20190630_def.xml EX-101.DEF 311729
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20190630_lab.xml EX-101.LAB 287861
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20190630_pre.xml EX-101.PRE 331884
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26422 | Film No.: 191027524
SIC: 2836 Biological Products, (No Diagnostic Substances)